Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Total stockholders’ equity		$ 10	$ 619,145	$ (118,890)
Balance, beginning of period at Dec. 31, 2021		10	619,145	(118,890)
Costs related to warrants			(55)
Stock-based compensation expense			13,750
Warrants issued with Senior Secured Term Loan			0
Stock issued under stock compensation plan			373
Issuance of common stock, net of issuance costs		0
Shares retained for employee taxes			0
Net income (loss)	$ (26,386)			(26,386)
Balance, end of period at Mar. 31, 2022	487,947	10	633,213	(145,276)
Total stockholders’ equity	487,947	10	633,213	(145,276)
Total stockholders’ equity	377,612	10	676,250	(298,648)
Balance, beginning of period at Dec. 31, 2022	377,612	10	676,250	(298,648)
Costs related to warrants			0
Stock-based compensation expense			14,065
Warrants issued with Senior Secured Term Loan			510
Stock issued under stock compensation plan			129
Issuance of common stock, net of issuance costs		0
Shares retained for employee taxes			(61)
Net income (loss)	(36,639)			(36,639)
Balance, end of period at Mar. 31, 2023	355,616	10	690,893	(335,287)
Total stockholders’ equity	$ 355,616	$ 10	$ 690,893	$ (335,287)